|
ES2537898T3
(es)
|
2005-10-25 |
2015-06-15 |
Shionogi & Co., Ltd. |
Derivados de aminotiazolidina y aminotetrahidrotiazepina como inhibidores de BACE 1
|
|
AU2006320374B2
(en)
|
2005-12-02 |
2012-08-30 |
Isis Pharmaceuticals, Inc. |
Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents
|
|
LT1993360T
(lt)
|
2005-12-28 |
2017-06-12 |
Vertex Pharmaceuticals Incorporated |
N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma
|
|
AU2007247385B2
(en)
*
|
2006-05-10 |
2011-07-14 |
Novartis Ag |
Bicyclic derivatives as CETP inhibitors
|
|
GB0609268D0
(en)
*
|
2006-05-10 |
2006-06-21 |
Novartis Ag |
Organic compounds
|
|
CN101443324A
(zh)
*
|
2006-05-11 |
2009-05-27 |
诺瓦提斯公司 |
作为cetp抑制剂的苄胺衍生物
|
|
US7750019B2
(en)
|
2006-08-11 |
2010-07-06 |
Kowa Company, Ltd. |
Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same
|
|
US7790737B2
(en)
|
2007-03-13 |
2010-09-07 |
Kowa Company, Ltd. |
Substituted pyrimidine compounds and their utility as CETP inhibitors
|
|
MX2009010050A
(es)
*
|
2007-03-23 |
2009-10-12 |
Amgen Inc |
Derivados de quinolina o quinoxalina 3-sustituidos y su uso como inhibidores de fosfotidilinositol 3-cinasa (p13k).
|
|
CA2683534C
(en)
|
2007-04-13 |
2015-02-24 |
Kowa Company, Ltd. |
Novel pyrimidine compound having dibenzylamine structure and medicament comprising the same
|
|
AU2008245082B8
(en)
|
2007-04-24 |
2012-09-13 |
Shionogi & Co., Ltd. |
Aminodihydrothiazine derivatives substituted with a cyclic group
|
|
EP2151435A4
(de)
|
2007-04-24 |
2011-09-14 |
Shionogi & Co |
Pharmazeutische zusammensetzung zur behandlung von morbus alzheimer
|
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
PL2207775T3
(pl)
|
2007-11-05 |
2012-08-31 |
Novartis Ag |
Pochodne 4-benzyloamino-1-karboksyacylo-piperydyny jako inhibitory CETP użyteczne do leczenia chorób, takich jak hiperlipidemia lub stwardnienie tętnic
|
|
AU2008333272B2
(en)
|
2007-12-03 |
2012-03-29 |
Novartis Ag |
1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
|
|
WO2009081105A2
(en)
|
2007-12-21 |
2009-07-02 |
Ucb Pharma S.A. |
Quinoxaline and quinoline derivatives as kinase inhibitors
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
BRPI0906473A8
(pt)
|
2008-01-04 |
2016-02-10 |
Intellikine Inc |
Certas entidades químicas, composições e métodos
|
|
US8637504B2
(en)
|
2008-06-13 |
2014-01-28 |
Shionogi & Co., Ltd. |
Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
|
|
WO2010030704A2
(en)
|
2008-09-10 |
2010-03-18 |
Achaogen, Inc. |
Antibacterial aminoglycoside analogs
|
|
WO2010030690A1
(en)
|
2008-09-10 |
2010-03-18 |
Isis Pharmaceuticals, Inc. |
Antibacterial 4,6-substituted 6', 6" and 1 modified aminoglycoside analogs
|
|
WO2010042850A1
(en)
|
2008-10-09 |
2010-04-15 |
Achaogen, Inc. |
Antibacterial aminoglycoside analogs
|
|
WO2010042851A1
(en)
|
2008-10-09 |
2010-04-15 |
Achaogen, Inc. |
Antibacterial aminoglycoside analogs
|
|
WO2010047372A1
(ja)
*
|
2008-10-22 |
2010-04-29 |
塩野義製薬株式会社 |
Bace1阻害活性を有する2-アミノピリミジン-4-オンおよび2-アミノピリジン誘導体
|
|
MX2011004375A
(es)
|
2008-10-23 |
2013-03-07 |
Vertex Pharma |
Moduladores del regulador de conductancia transmembrana de fibrosis quistica.
|
|
US8314239B2
(en)
|
2008-10-23 |
2012-11-20 |
Vertex Pharmaceutical Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
US8513284B2
(en)
|
2009-02-13 |
2013-08-20 |
Ucb Pharma, S.A. |
Fused pyridine and pyrazine derivatives as kinase inhibitors
|
|
SG176628A1
(en)
|
2009-06-05 |
2012-01-30 |
Link Medicine Corp |
Aminopyrrolidinone derivatives and uses thereof
|
|
EP2448938B9
(de)
|
2009-06-29 |
2015-06-10 |
Incyte Corporation |
Pyrimidinone als pi3k-hemmer
|
|
CA2777107A1
(en)
|
2009-10-09 |
2011-04-14 |
Achaogen, Inc. |
Antibacterial aminoglycoside analogs
|
|
RU2012129168A
(ru)
|
2009-12-11 |
2014-01-20 |
Сионоги Энд Ко. Лтд. |
Производные оксазина
|
|
WO2011075643A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as pi3k inhibitors
|
|
WO2011075630A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
|
|
EP2558463A1
(de)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Kondensierte derivate als i3-hemmer
|
|
CA2798330A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
|
JP5951600B2
(ja)
|
2010-05-21 |
2016-07-13 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
キナーゼ調節のための、化合物、組成物および方法
|
|
EP2582709B1
(de)
|
2010-06-18 |
2018-01-24 |
Sanofi |
Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
|
|
US9062055B2
(en)
|
2010-06-21 |
2015-06-23 |
Incyte Corporation |
Fused pyrrole derivatives as PI3K inhibitors
|
|
MX2013000359A
(es)
|
2010-07-09 |
2013-02-11 |
Ube Industries |
Compuesto de piridina sustituida.
|
|
EP2593447B1
(de)
|
2010-07-15 |
2016-08-17 |
Bayer Intellectual Property GmbH |
3-pyridyl-heteroarylcarboxamidverbindungen als schädlingsbekämpfungsmittel
|
|
TWI642670B
(zh)
*
|
2010-09-14 |
2018-12-01 |
伊塞利克斯公司 |
Pi3k-德爾塔抑制劑以及其應用和生產方法
|
|
CA2816285A1
(en)
|
2010-10-29 |
2012-05-03 |
Shionogi & Co., Ltd. |
Naphthyridine derivative
|
|
US9018219B2
(en)
|
2010-10-29 |
2015-04-28 |
Shionogi & Co., Ltd. |
Fused aminodihydropyrimidine derivative
|
|
CN103282370A
(zh)
|
2010-11-17 |
2013-09-04 |
尔察祯有限公司 |
抗菌氨基糖苷类类似物
|
|
JP5961187B2
(ja)
|
2010-12-20 |
2016-08-02 |
インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation |
Pi3k阻害剤としてのn−(1−(置換フェニル)エチル)−9h−プリン−6−アミン
|
|
WO2012088266A2
(en)
|
2010-12-22 |
2012-06-28 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
|
|
EP3238722B1
(de)
|
2011-01-10 |
2019-03-13 |
Infinity Pharmaceuticals, Inc. |
Festen formen von isochinolinonen
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2012120055A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120054A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
GB201104267D0
(en)
|
2011-03-14 |
2011-04-27 |
Cancer Rec Tech Ltd |
Pyrrolopyridineamino derivatives
|
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
|
WO2012147763A1
(ja)
|
2011-04-26 |
2012-11-01 |
塩野義製薬株式会社 |
オキサジン誘導体およびそれを含有するbace1阻害剤
|
|
CN103648495A
(zh)
|
2011-07-08 |
2014-03-19 |
诺华股份有限公司 |
在高甘油三酯对象中治疗动脉粥样硬化的方法
|
|
US9056877B2
(en)
|
2011-07-19 |
2015-06-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
PE20141371A1
(es)
|
2011-08-29 |
2014-10-13 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y usos de los mismos
|
|
MX389479B
(es)
|
2011-09-02 |
2025-03-20 |
Incyte Holdings Corp |
Heterociclilaminas como inhibidores de fosfoinositida 3-cinasas (pi3k)
|
|
IN2014CN02290A
(de)
*
|
2011-09-27 |
2015-06-19 |
Reddys Lab Ltd Dr |
|
|
CA2860601C
(en)
|
2012-01-06 |
2016-07-05 |
Daiichi Sankyo Company, Limited |
Acid addition salt of substituted pyridine compound
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
SG11201406584TA
(en)
|
2012-04-24 |
2014-11-27 |
Vertex Pharma |
Dna-pk inhibitors
|
|
CA2876689C
(en)
|
2012-06-13 |
2022-04-26 |
Incyte Corporation |
Substituted tricyclic compounds as fgfr inhibitors
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
JPWO2014017569A1
(ja)
*
|
2012-07-26 |
2016-07-11 |
興和株式会社 |
血中ldlを低下させるための医薬
|
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
|
GB201216018D0
(en)
|
2012-09-07 |
2012-10-24 |
Cancer Rec Tech Ltd |
Pharmacologically active compounds
|
|
JP2016501827A
(ja)
|
2012-10-24 |
2016-01-21 |
塩野義製薬株式会社 |
Bace1阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体
|
|
RU2702908C2
(ru)
|
2012-11-01 |
2019-10-14 |
Инфинити Фармасьютикалз, Инк. |
Лечение злокачественных опухолей с использованием модуляторов изоформ pi3-киназы
|
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
|
RS62649B1
(sr)
|
2013-03-12 |
2021-12-31 |
Vertex Pharma |
Inhibitori dnk-pk
|
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
PH12015502383B1
(en)
|
2013-04-19 |
2023-02-03 |
Incyte Holdings Corp |
Bicyclic heterocycles as fgfr inhibitors
|
|
GB201314452D0
(en)
|
2013-08-13 |
2013-09-25 |
Ostara Biomedical Ltd |
Embryo implantation
|
|
KR102411227B1
(ko)
|
2013-10-17 |
2022-06-21 |
버텍스 파마슈티칼스 인코포레이티드 |
Dna-pk 억제제로서 (s)-n-메틸-8-(1-((2'-메틸-[4,5'-비피리미딘]-6-일)아미노)프로판-2-일)퀴놀린-4-카복스아미드 및 이의 듀테로화된 유도체의 공결정
|
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
US10077277B2
(en)
|
2014-06-11 |
2018-09-18 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
|
|
GB201415569D0
(en)
|
2014-09-03 |
2014-10-15 |
C4X Discovery Ltd |
Therapeutic Compounds
|
|
CA2963945C
(en)
|
2014-10-07 |
2023-01-10 |
Vertex Pharmaceuticals Incorporated |
Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
|
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
GB201501302D0
(en)
|
2015-01-27 |
2015-03-11 |
Ostara Biomedical Ltd |
Embryo implantation
|
|
US9580423B2
(en)
|
2015-02-20 |
2017-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
|
CA2976790C
(en)
|
2015-02-20 |
2024-02-27 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
SG10201912302VA
(en)
|
2015-02-27 |
2020-02-27 |
Incyte Corp |
Salts of pi3k inhibitor and processes for their preparation
|
|
US9745253B2
(en)
|
2015-03-13 |
2017-08-29 |
Forma Therapeutics, Inc. |
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
|
|
WO2016183060A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
|
US9988401B2
(en)
|
2015-05-11 |
2018-06-05 |
Incyte Corporation |
Crystalline forms of a PI3K inhibitor
|
|
GB201517523D0
(en)
|
2015-10-05 |
2015-11-18 |
Ostara Biomedical Ltd |
Methods and compositions for managing reproduction
|
|
KR101947976B1
(ko)
|
2015-12-15 |
2019-02-13 |
아스트라제네카 아베 |
이소인돌 화합물
|
|
GB201601703D0
(en)
|
2016-01-29 |
2016-03-16 |
C4X Discovery Ltd |
Therapeutic compounds
|
|
EP3474856B1
(de)
|
2016-06-24 |
2022-09-14 |
Infinity Pharmaceuticals, Inc. |
Kombinationstherapie
|
|
US10906888B2
(en)
|
2016-07-14 |
2021-02-02 |
Pfizer Inc. |
Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme
|
|
EP3484528B1
(de)
|
2016-07-18 |
2020-11-25 |
Janssen Pharmaceutica NV |
Tau-pet-bildgebungsliganden
|
|
MX394860B
(es)
|
2016-09-27 |
2025-03-24 |
Vertex Pharma |
Metodo para tratar cancer usando una combinacion de agentes que dañan adn e inhibidores de proteina cinasa dependiente de adn (adn-pk).
|
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
|
EP3638661A1
(de)
|
2017-06-14 |
2020-04-22 |
Astrazeneca AB |
Als ror-gamma-modulatoren verwendbare 2,3-dihydroisoindol-1-carboxamide
|
|
KR102956194B1
(ko)
|
2018-05-04 |
2026-04-23 |
인사이트 코포레이션 |
Fgfr 억제제의 염
|
|
RS66310B1
(sr)
|
2018-05-04 |
2025-01-31 |
Incyte Corp |
Čvrsti oblici inhibitora fgfr i procesi za njegovu pripremu
|
|
IL278889B2
(en)
|
2018-06-01 |
2025-11-01 |
Incyte Corp |
Dosing regimen for the treatment of pi3k related disorders
|
|
WO2020185532A1
(en)
|
2019-03-08 |
2020-09-17 |
Incyte Corporation |
Methods of treating cancer with an fgfr inhibitor
|
|
WO2021007269A1
(en)
|
2019-07-09 |
2021-01-14 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
US12122767B2
(en)
|
2019-10-01 |
2024-10-22 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
GEP20247679B
(en)
|
2019-10-14 |
2024-10-10 |
Incyte Corp |
Bicyclic heterocycles as fgfr inhibitors
|
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
MX2022006691A
(es)
|
2019-12-04 |
2022-09-19 |
Incyte Corp |
Derivados de un inhibidor de receptores del factor de crecimiento de fibroblastos (fgfr).
|
|
WO2021113479A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
PH12022551379A1
(en)
|
2019-12-06 |
2023-05-03 |
Vertex Pharma |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
CN117098541A
(zh)
|
2020-11-25 |
2023-11-21 |
阿卡格拉医药公司 |
用于递送核酸的脂质纳米粒及相关使用方法
|
|
EP4323405A1
(de)
|
2021-04-12 |
2024-02-21 |
Incyte Corporation |
Kombinationstherapie mit einem fgfr-inhibitor und einem auf nectin-4 abzielenden mittel
|
|
SI4347031T1
(sl)
|
2021-06-04 |
2026-01-30 |
Vertex Pharmaceuticals Incorporated |
N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
|
|
CA3220274A1
(en)
|
2021-06-09 |
2022-12-15 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
TW202313610A
(zh)
|
2021-06-09 |
2023-04-01 |
美商英塞特公司 |
作為fgfr抑制劑之三環雜環
|
|
WO2023230587A2
(en)
|
2022-05-25 |
2023-11-30 |
Akagera Medicines, Inc. |
Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
|
|
CN117105798A
(zh)
*
|
2023-08-10 |
2023-11-24 |
妆莱(广州)生物研究有限公司 |
一种壬二酰胺mea的制备方法
|